US Patent 9555014 Therapeutic regimens
Patent 9555014 was granted and assigned to Radius Health on January, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+217 characters)
Article
Patent abstract
This invention relates to clinically useful therapeutic regimens comprising the administration of (R)-6-(2-(ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
C. Richard Lyttle0
Jonathan Guerriero0
Louis O'Dea0
Edits on 26 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09555014 Therapeutic regimens US Patent 9555014 Therapeutic regimens
Infobox
Patent Number
09555014
Patent Number
9555014
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09555014 Therapeutic regimens
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09555014
Date of patent
January 31, 2017
Patent application number
14281475
Date Filed
May 19, 2014
Patent primary examiner
Find more entities like US Patent 9555014 Therapeutic regimens
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.